The U.S. House version of a bill reauthorizing FDA review user fees would add employment and economic considerations to the federal watchdog agency’s mission statement.
FDA officials and consumer advocates balked yesterday at legislative attempts to alter the federal watchdog agency’s mission statement to include promoting job growth, competition and economic growth.
A U.S. House version of a bill reauthorizing FDA user fees for medical devices and pharmaceuticals would include economic obligations FDA officials said would distract from the agency’s responsibility to patients.
The revision, proposed by Rep. Mike Rogers (R-Mich.), wasn’t well received by FDA devices chief Dr. Jeffrey Shuren, MedPageToday reported.
